ADVISORY/Harvard & Georgetown Physicians Present Breakthrough Research at EXPO WEST; Human Clinical Studies Produce Arthritis and Obesity Breakthroughs.News/Assignment Editors & Health/Medical Writers EXPO WEST ADVISORY...for Saturday (March 9) --(BW HealthWire)-- Seminar I Obesity Breakthrough Georgetown's Dr. Harry Pruess will present results of the most comprehensive human clinical study every conducted on (-)hydroxycitric acid Hydroxycitric acid (HCA) is a derivative of citric acid that is found in a variety of tropical plants including Garcinia cambogia and Hibiscus subdariffa. (HCA HCA, n.pr See acid, hydroxycitric. ). He will introduce a new super-HCA that results in dramatic weight loss while down-regulating the obesity gene and increasing levels of serotonin serotonin (sĕr'ətō`nĭn), organic compound that was first recognized as a powerful vasoconstrictor occurring in blood serum. It was partially purified, crystallized, and named in 1948, and its structure was deduced a year later. , a neurotransmitter neurotransmitter, chemical that transmits information across the junction (synapse) that separates one nerve cell (neuron) from another nerve cell or a muscle. Neurotransmitters are stored in the nerve cell's bulbous end (axon). that helps control appetite. Dr. Pruess will also introduce an even more potent weight loss formula combining this super-potent HCA (Super CitriMax(TM)); niacin-bound chromium (ChromeMate(R)), found to increase fat loss, while sparing muscle; and Gymnema sylvestre Gymnema sylvestre, n See gymnema. , an Ayurvedic herb that promotes insulin secretion and helps maintain healthy cholesterol and blood glucose levels blood glucose level, n level of glu-cose in the bloodstream, normally about 70 to 115 mg/dL after fasting overnight. Higher levels may indicate diseases such as diabetes mellitus. .
WHO: Dr. Harry Pruess, professor of physiology, medicine and
pathology
Georgetown University Medical Center
WHAT: Results of the most comprehensive HCA clinical study ever
conducted.
WHEN: Saturday, March 9, 2002; 12:30 - 1:30 p.m.
WHERE: EXPO WEST, Anaheim Convention Center, Room 205B
Seminar II -- Immune-Related Arthritis Breakthrough Harvard's Dr. David Trentham will present results of four human clinical studies, demonstrating the benefits of undenatured type II collagen in the treatment of immune-related arthritis. These findings definitively show how "oral tolerization" and the use of undenatured type II collagen can produce profound benefits in the treatment of arthritis. Not to be confused with denatured de·na·ture tr.v. de·na·tured, de·na·tur·ing, de·na·tures 1. To change the nature or natural qualities of. 2. type II collagen, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Dr. Trentham, "Type II collagen must be in its native (undenatured) form to be effective." At the seminar, he will clarify the difference between the two and explain why only undenatured type II collagen is effective in the treatment of arthritis.
WHO: Dr. David Trentham, noted researcher and professor of medicine
Harvard Medical School
WHAT: Undenatured Type II Collagen: Arthritis Treatment Breakthrough
WHEN: Saturday, March 9, 2002; 3:00 - 4:00 p.m.
WHERE: EXPO WEST, Anaheim Convention Center, Room 205B
Both seminars are sponsored by InterHealth Nutraceuticals, maker of CitriMax(TM) and Super CitriMax(TM) (patent pending), the world's #1 selling HCA diet ingredients, and UC-II(TM) (U.S. Patents 5,645,581, 5,637,321, 5,529,786 and 5,750,144, and worldwide patents pending), the only source of undenatured type II collagen available in the marketplace. InterHealth researches, develops, manufactures, markets and distributes specialty nutritional ingredients. In addition to CitriMax(TM), Super CitriMax(TM), and UC-II(TM), InterHealth is the maker of ChromeMate(R), Protykin(R) and L-OptiZinc(R). |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion